Published in Gene Therapy Weekly, April 1st, 1996
Epidemic fulminant hepatitis B in multiple contacts of a single hepatitis B virus strain provides a unique opportunity to investigate the genetic basis of fulminant hepatitis B, since host factors, including immune responses or human leukocyte antigen (HLA) haplotypes, can be excluded for consideration in this setting.
Researcher Yasuhio Asahina and colleagues sought to determine the complete nucleotide sequences of hepatitis B virus (HBV) genomes obtained...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.